Stopped: study transitioned from LIRB to CIRB
In order to ensure the equity of the liver allocation process, it is important to create objective, scientifically validated markers of frailty in patients with end-stage liver disease that accurately predict patient outcomes. Many measures have been developed to assess this clinical state in elderly patients, but none have been applied to patients with cirrhosis, a population at increased risk for accelerated functional decline. This protocol is designed to learn more about the effects of functional status (also known as "frailty") in liver transplant patients and patient outcomes both before and after liver transplant.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Fried Frailty Index measurements in 300 patients with end-stage liver disease awaiting liver transplantation
Timeframe: 5 years
Liver Frailty Index measurements in 300 patients with end-stage liver disease awaiting liver transplantation
Timeframe: 5 years
Numbers Connection test measurements in 300 patients with end-stage liver disease
Timeframe: 5 years
Work status
Timeframe: 5 years
Hospitalizations
Timeframe: 5 years
Activities of daily living (ADLs)
Timeframe: At 1 year post transplantation
Instrumental Activities of Daily Living (IADLs)
Timeframe: At 1 year post transplantation
36 Item Short Form Survey Instrument (SF-36)
Timeframe: At 1 year post transplantation